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Abstract
Background: The increasing age of the population, especially in the western world, means that
the prevalence of osteoarthritis is also increasing, with corresponding socioeconomic
consequences. Although there is no curative intervention at present, in accordance with US and
European guidelines, pharmacotherapeutic and non-pharmacological approaches aim at pain
control and the reduction of functional restriction.
It has been established that hydrotherapy for osteoarthritis of the hip or knee joint using serial cold
and warm water stimulation not only improves the range of movement but also reduces pain
significantly and increases quality of life over a period of up to three months. Weight reduction is
important for patients with osteoarthritis of the hip or knee. In addition, conventional
physiotherapy and exercise therapy have both been shown, at a high level of evidence, to be cost-
effective and to have long-term benefits for pain relief, movement in the affected joint, and patient
quality of life.
Methods/design: The study design consists of a prospective randomised controlled three-armed
clinical trial, which will be carried out at a specialist clinic for integrative medicine, to investigate
the clinical effects of hydrotherapy on osteoarthritis of the knee or hip joint, in comparison with
conventional physiotherapy.
One hundred and eighty patients diagnosed with osteoarthritis of hip or knee will be randomly
assigned to one of three intervention groups: hydrotherapy, physiotherapy, and both physiotherapy
and hydrotherapy of the affected joint. In the first group, patients will receive Kneipp hydrotherapy
daily, with water applied in the form of alternate cold and warm thigh affusions (alternating cold
and warm water stimulation is particularly relevant to the knee and hip regions).
Patients in the second group will receive physiotherapy of the hip or knee joint three times a week.
Patients in the physiotherapy-hydrotherapy combination group will receive both joint-specific
physiotherapy three times a week and alternate cold and warm thigh affusions every day. Follow-
up assessments will be on three levels: clinical assessment by the investigator; subjective patient
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assessment consisting of a patient diary, and questionnaires on admission and at the end of the
treatment phase; and a final telephone assessment by the external evaluation centre. Assessments
will be made at baseline, after two weeks of inpatient treatment, and finally after a further ten
weeks of follow-up. The primary outcome measure will be pain intensity of the affected joint in the
course of inpatient treatment, judged by the patient and the investigator. Secondary outcomes
include health-related quality of life and joint-specific pain and mobility in the course of the study.
Statistical analysis of the results will be on an intention-to-treat basis.
Conclusion: This study methodology has been conceived according to the standards of the
CONSORT recommendations. The results will contribute to establishing hydrotherapy as a non-
invasive, non-interventional, reasonably priced, therapeutic option with few side effects, in the
concomitant treatment of osteoarthritis of the hip or knee.
Trial Registration: Trial registration number: NCT 00950326
Background
Osteoarthritis (OA) is the most common and most endur-
ing physical impairment of patients in the western world;
age is known to be one of the most important risk factors
for this disease. It affects approximately 10% of all people
over 60, with estimated socioeconomic consequential
costs of about 60 billion dollars per year in the US alone
[1].
As well as considering osteoarthritis to be a result of
mechanical irritation, attrition and erosion of the cartilage
matrix, another scientific hypothesis postulates a loss of
vital cartilage cells and cartilage matrix degeneration [2].
Obesity, with a BMI >26, is considered a predictive marker
for osteoarthritis of the knee or hip joint [3].
The clinical picture of osteoarthritis is characterised
mainly by joint pain, crepitus, joint stiffness after rest,
hyperthermia, and progressively restricted movement.
Along with overweight, preventable or at least modifiable
risk factors are physical activity, nutrition, and hormonal
influences [4].
Although there is no curative intervention at present, in
accordance with US and European guidelines, pharmaco-
therapeutic and non-pharmacological approaches aim to
control pain and reduce reduction of functional restric-
tion. Non-pharmacological therapy comprises a multidis-
ciplinary approach consisting, for example, of
instructions for weight loss and exercise therapy; pharma-
cotherapy comprises non-opioid analgesics, non-steroidal
anti-inflammatory drugs (NSAIDs) including COX-2
inhibitors, topical analgesics (e.g. capsaicin cream), and
opioid analgesics, as well as intra-articular steroid and
hyaluronic acid injections [5].
Various epidemiological studies showed that NSAIDs
were prescribed for 86.9% of patients, analgesics for
29.9% received, chondroprotectives for 7.6%, and gastro-
protective drugs for 36.9% [6]. In just one year in France,
17 million prescriptions and five million days' absence
from work were documented because of osteoarthritis [7].
NSAIDs have gastrointestinal side-effects, so complemen-
tary and alternative medicine (CAM) is increasingly offer-
ing concomitant therapeutic options. The prevalence of
the use of CAM in osteoarthritis is estimated to be 40%:
vitamin supplements, celery extract, fish oil, and garlic
extract are often part of patient self-medication [8]. CAM
further offers evaluated therapeutic procedures, including
acupuncture, various herbal agents such as stinging nettle,
boswellic acid, devil's claw extract, and proteins such as
glucosamine [9,10]. Besides acupuncture and glu-
cosamine, systematic reviews have also evaluated pool
therapy, balneotherapy, thermotherapy, and exercise ther-
apy, and found beneficial outcomes for pain and move-
ment restriction in osteoarthritis of the hip or knee [11-
14].
Patient surveys showed that 80% of patients with osteoar-
thritis had used several complementary medical proce-
dures in the previous month; 52% used over the counter
medicines. Other approaches taken were dietary measures
(71.5%); mind-body techniques (42.4%), salves and oint-
ments and other topical applications (38.1%), taking vita-
mins and/or trace elements (32.9%), herbal preparations,
and various physical manipulation techniques (21.4%)
[15].
Several basic articles describe Kneipp hydrotherapy (e.g.
in the form of alternate cold and warm thigh affusions) as
having an active effect on the vessels by causing initial
local vasoconstriction followed by reflexive vasodilata-
tion, which activates the cutaneous circulation [16-18].
Furthermore, modulation of hormone production was
scientifically demonstrated for cortisol and adrenaline
[19-21].BMC Musculoskeletal Disorders 2009, 10:104 http://www.biomedcentral.com/1471-2474/10/104
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Immunologically, hydrotherapy increases serum concen-
trations of alpha-2 macroglobulin, IgM antibodies, and
complement factor C3 [22]. In addition, using alternate
cold and warm back affusions, positive effects were found
on immunoregulation, in the sense of an increase in
resistance and facilitated activation of cell-mediated (Th1)
immune reactions, as measured by the mediating
cytokines IFN-gamma and IL-2 [23].
Serial cold and warm water stimulation hydrotherapy for
osteoarthritis of the hip or knee joint showed improve-
ment of restricted joint mobility, along with significant
pain reduction and increase in quality of life over a period
of up to three months [24,25].
In particular, serial application of alternate cold and warm
thigh affusions (Figure 1) has established itself as con-
comitant therapy for osteoarthritis of the hip or knee; this
therapeutic application is also indicated for adjuvant
treatment of peripheral arterial disease and insomnia. The
thigh affusion is poured starting from the back of the foot
up the outer aspect of the back of the leg, slowly over the
buttocks ("starting away from the heart going towards the
heart"), from there moving to the front aspect of the leg,
lingering in the groin, and finally pouring the water over
the inner aspect of the leg downwards [26].
Weight reduction is important for patients with osteoar-
thritis of the hip or knee. In addition, conventional phys-
iotherapy and movement therapy have both been shown,
at a high level of evidence, to be cost-effective and to have
long-term benefits for pain, movement in the affected
joint, and patient quality of life [27-29].
This randomised clinical trial will be funded by the Otto
Schönfisch Foundation, Bad Wörishofen, Germany
(Project number: Dr.Wa/zie/2.7.08).
Methods/design
Research aims and questions
The main aim of this three-armed clinical study will be to
determine the effects of hydrotherapy with alternate cold
and warm affusions of the thigh in the concomitant treat-
ment of osteoarthritis of the hip or knee. The main out-
come measures are pain reduction, improvement in the
quality of life, and increased movement in the affected
joint.
Research questions
1. Does Kneipp hydrotherapy show a measurable
effect in the sense of altered clinical findings in the
affected knee or hip joint?
2. How effectively does hydrotherapy influence the
clinical parameters of pain, range of movement, and
function of the affected joint?
3. How effectively does hydrotherapy affect the sec-
ondary outcome measures of quality of life, pain expe-
rienced, mood, and blood pressure?
4. Do hydrotherapeutic applications simply provide
short-term therapeutic success or are there long-term
changes in the clinical findings?
5. Are the clinical effects of hydrotherapy comparable
with those of conventional physiotherapy of the
affected joint?
6. Are the clinical effects of hydrotherapy used as mon-
otherapy comparable with a combination of hydro-
therapy and physiotherapy of the affected joint?
7. Do unwanted effects or side effects occur with
hydrotherapy?
Study duration
January 2009 – December 2010
Design
This study was designed as a prospective randomised con-
trolled clinical trial with three arms, which is to be carried
Alternate thigh affusion according to Kneipp – flow direction  (repeated cold/warm water stimulation) Figure 1
Alternate thigh affusion according to Kneipp – flow 
direction (repeated cold/warm water stimulation). 
The thigh affusion is poured starting from the back of the 
foot up the outer aspect of the back of the leg, slowly over 
the buttocks ("starting away from the heart going towards 
the heart"), from there moving to the front aspect of the leg, 
lingering in the groin, and finally pouring the water over the 
inner aspect of the leg downwards.BMC Musculoskeletal Disorders 2009, 10:104 http://www.biomedcentral.com/1471-2474/10/104
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out at a German clinic specialised in integrative medicine,
to investigate the clinical effects of hydrotherapy on oste-
oarthritis of the knee or hip, as compared with conven-
tional physiotherapy.
To achieve maximum scientific accuracy with respect to
randomisation, random distribution, avoidance of selec-
tion bias, etc., the independent Department of General
Medicine and Primary Care of the University of Leipzig
Medical School will function as an external evaluation
and testing centre.
The design and concept of this study, as well as its ethical
validity, were reviewed and approved by the Ethics Com-
mittee of the Bavarian State Chamber of Physicians
[Ethikkommission der Bayerischen Landesärztekammer],
(Study Number 08032, dated 04.05.2008).
Subjects
All patients of a German clinic for integrative medicine
who have symptomatic osteoarthritis of the hip or knee
joint, who meet the revised criteria of the American Col-
lege of Rheumatology, who have agreed to participate in
the study, given their informed consent and signed a data
privacy policy statement, will be included in the study.
Patients will be given an information sheet, which will tell
them they will be randomly assigned to one of the three
following treatment groups:
In group 1, patients will receive a specific hydrothera-
peutic procedure in the form of alternate cold and
warm thigh affusions (pouring on water) which will
consist of repeated cold and warm water stimulation
of the knee and hip region. Physiotherapy of other
regions, such as the back, is permitted but there will be
no specific physiotherapy of the hip or knee joint.
In Group 2, patients will be given physiotherapy of
the hip or knee joint three times a week but no thigh
affusions. Affusions of other regions, such as the back,
are permitted.
In Group 3, patients will receive not only joint-spe-
cific physiotherapy of the hip or knee joint but also
daily thigh affusions of alternate cold and warm water.
The patients will be informed of possible unwanted side-
effects; in addition they will be told that they can with-
draw from the study at any time without any fear that they
will not continue to receive treatment.
The inclusion and exclusion criteria are to be found in
Table 1.
After the treating physician has clinically examined a
patient with osteoarthritis of the hip or knee and con-
firmed that all the inclusion criteria and none of the exclu-
sion criteria are met, the patient will be given the
information sheet, a statement of informed consent, and
a privacy policy statement for this clinical study. If the
patient agrees to take part, the external evaluation centre
will be informed, and will send the investigator a plain
Table 1: Eligibility criteria
Inclusion criteria
1A g e   ≥ 18 years
2 Symptomatic osteoarthritis of hip or knee (following the revised criteria of the American College of Rheumatology)
3 Willingness to comply with follow-up assessments and treatment
4 Ability to understand, read and speak German
Exclusion criteria
1 Endoprothetic replacement of hip or knee joint
2 Inflammatory arthropathy of the hip or the knee
3 Acute, hot, red and swollen knee or hip joint (unknown focus)
4 Inflammatory system diseases which could interfere with the evaluation of the therapy procedure
5 CNS diseases, especially epilepsy
6 Anamnesis of deep vein thrombosis in the past 12 months
7 Severe lung disease such as e.g. COPD stages GOLD III – GOLD IV
8 Heart failure NYHA III – NYHA IV
9 Myocardial ischemia with or without intervention within the last 3 months before inpatient admission
10 Cancer in advanced stage
11 Large skin wounds or inflammatory and ulcerated dermatosis of the legs
12 Severe febrile infectious diseases Non treated hypertension
13 Participation in another clinical study within the past four weeks
14 PregnancyBMC Musculoskeletal Disorders 2009, 10:104 http://www.biomedcentral.com/1471-2474/10/104
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envelope with a randomisation number, treatment group
assignment, and the necessary study documents.
Randomisation and treatment allocation
Based on the results of a pilot study, a randomisation
number list and treatment group assignment has been
generated by software before the beginning of the main
study. When the envelope is opened, the investigator and
patient will come to know the treatment group assign-
ment (group 1, 2, or 3) with a corresponding treatment
plan in line with the study protocol, the patient diary for
the inpatient treatment phase, and all the necessary assess-
ment forms for both doctor and patient.
Prior to the study, all medical specialists in the clinic and
attending therapists have been given a briefing on the
study protocol, the ethical basis of this clinical study, the
randomisation procedure, and the specific therapy for
each treatment group, in line with the study protocol.
Sample size
On the basis of the data from the pilot study, carried out
between June 2008 and January 2009 at the Kneipp Clinic
in Bad Wörishofen, Germany, on 30 patients with pre-
existing osteoarthritis of the hip or knee, a sample size was
estimated using G-Power 3.0.10 software (Faul F, Erd-
felder E, Lang A.-G, and Buchner A, 2007). According to
this calculation, a sample size of n = 180 patients will suf-
fice to determine a possible interaction between the
groups with respect to the primary outcome, with a statis-
tical power of 95%.
Interventions
The study will divided into a clinical or treatment phase
(two weeks' inpatient therapy) and a follow-up phase of
a further ten weeks, ending with a telephone interview to
be carried out by the external evaluation centre (Figure 2).
During the clinical phase the following interventions will
be applied:
In intervention group 1, the patient will receive hydro-
therapy appropriate for osteoarthritis of the hip or knee,
in the form of daily thigh affusions of alternate cold and
warm water. In this group, physiotherapy may also be
given but not specifically for the affected hip or knee joint.
In intervention group 2, patients with osteoarthritis of
the hip or knee will receive specific physiotherapy of the
affected hip or knee joint three times a week, but without
any disease-specific hydrotherapy. Because of the holistic
approach of the clinic, however, these patients will still
receive hydrotherapy at sites other than the affected joint,
for example, alternate cold and warm affusions of the
back or an ascending lumbar affusion.
In group 3, the control group, patients with active oste-
oarthritis of the hip or knee will receive specific, joint-
related hydrotherapy in the form of a (daily) alternate
cold and warm thigh affusions as well as joint-specific
physiotherapy (three times a week).
Diagnostic and biometric evaluation procedure
Each patient will undergo a medical examination at the
time of admission and a final examination after two
weeks of inpatient therapy, in which the general physical
state and disease-specific previous medication and ther-
apy will be documented. At the two medical examina-
tions, pain intensity will be measured on a ten-point
visual analogue scale, and 1) diagnostic assessment of the
affected joint according to the neutral-zero method (hip
joint: flexion and extension, internal and external rota-
tion; knee joint: flexion and extension); 2) the timed "up
and go" (TUG test) as an indirect assessment criterion of
flexion and extension in the affected hip or knee joint; and
3) the body mass index (BMI) will be recorded in the case
report form or physician's questionnaire.
Independently of the doctor, a standardised question-
naire will be filled out by the patient at the time of admis-
sion and after two weeks of inpatient therapy. These
questionnaires will be sent to the evaluation centre
directly after they are handed in.
The same assessment will be carried out in a telephone
interview by the external study centre, ten weeks after the
end of inpatient care.
The assessment includes A) the SF-36 test, B) the Lequesne
hip or knee questionnaire, C) the AIM-2-SF Scales 2 Short
Form, and D) the EQ-5D test.
In addition, each patient will be given a diary for self-
reporting during inpatient treatment. This diary will be
completed by the patient: it contains the subjective visual
analogue scale, the current mental health state scale of the
EQ-5 D test, and blood pressure measurements (filled out
by the nursing staff) ((Figure 3)).
Outcome measures
Primary outcome measure
The primary outcome measure will be the pain intensity
of the affected joint during inpatient care, as assessed by
the patient and the investigator. The patient rates subjec-
tive pain intensity in the patient diary on a ten-point vis-
ual analogue scale (0 = no pain; 10 = greatest pain
imaginable); the doctor also records pain intensity
around the affected joint on a ten-point visual analogue
scale. The use, practicality, and validity of visual analogue
scales have been sufficiently evaluated and are scientifi-
cally accepted [30,31]BMC Musculoskeletal Disorders 2009, 10:104 http://www.biomedcentral.com/1471-2474/10/104
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Secondary outcome measures
I) Mobility of the affected joint
The mobility of the affected hip or knee joint is docu-
mented by the investigator at the time of admission
and the time of discharge from the clinic, using the
neutral-zero method and range of motion scale. Flex-
ion and extension, internal and external rotation are
recorded for the hip joint, as are flexion and extension
for the knee joint.
II) Quality of life rating for the patient with osteoarthritis, on the basis 
of the German version of the Arthritis Impact Measurement Scale 
(AIMS2)
The practicality, reliability and validity of the Arthritis
Impact Measurement Scale (AIMS2) have been con-
firmed in many studies, and for this reason it is used
in judging the quality of life in patients with osteoar-
thritis. Its inherent consistency and reliability are sim-
ilar to those of the WOMAC score, with Cronbach's
alpha at 0.77 or higher [32]. The patient will docu-
ment this index at the beginning and end of the
inhouse treatment period, and it will again be
recorded by the external evaluation centre on the basis
of the telephone interview at the end of the ten-week
follow-up.
III) Joint-specific pain and function rating on the basis of the Lequesne 
index
The Lequesne index is a patient-centred assessment
(self-rating procedure) in the form of a questionnaire.
It is available in two closely related versions (hip or
knee joint diseases), and includes pain, walking per-
formance, and coping with daily living. The evalua-
tion shows high reliability, validity, and sensitivity to
change.
Flowchart describing the participant flow through the study Figure 2
Flowchart describing the participant flow through the study. Diagramm over the participant flow through recruit-
ment, randomization, baseline measurement, post-treatment and 3 month follow-up.
Study group includes N=180 patients 
with hip or knee osteoarthritis,
randomly assigned into intervention 
groups
Exclusion criteria:
All patients with 
contraindications for 
conventional physiotherapy or 
hydrotherapy
Hydrotherapy
N= 60 patients
  Physiotherapy
N= 60 patients
Hydro- and Physiotherapy
N = 60 patients
Completed questionnaire at admission examination/baseline:
Patient questionnaire: SF-36, AIMS2-SF, Lequesne knee and hip questionnaire, EQ5D
Physician documentation: Timed up and go, VAS, Range-of-motion affected joint
Issue patient journal
Repeat questionnaire completion at final medical examination after 2 weeks:
Patient questionnaire: SF-36, AIMS2-SF, Lequesne knee and hip questionnaire, EQ5D
Physician documentation: Timed up and go, VAS, Range-of-motion affected joint
Issue patient journal
Telephone interview 10 weeks after release from clinic:
SF-36, AIMS2-SF, Lequesne knee or hip questionnaireBMC Musculoskeletal Disorders 2009, 10:104 http://www.biomedcentral.com/1471-2474/10/104
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As a self-rating procedure, the Lequesne index is not
subject to the influence of the investigator or therapist.
There is no investigator bias, which always has to be
recognised within procedures combining self-rating
and rating by another person. The Lequesne index is
therefore a suitable assessment tool for quality assur-
ance [33,34]. The patient will document this index for
the affected joint at the beginning and end of the
inhouse treatment period, and it will again be
recorded by the external evaluation centre on the basis
of the telephone interview at the end of the ten-week
follow-up.
IV) Rating the general health-related quality of life on the basis of the 
SF-36, short version
The SF-36 is an internationally recognised tool for
ascertaining patients' health-related quality of life in a
wide range of diseases. It comprises two summation
scales and eight dimensions, which can be divided
into the areas of "physical health" and "mental
health". The inherent consistency (Cronbach's alpha)
for "physical function" is between 0.77 and 0.93,
between 0.73 and 0.85 for "pain", and between 0.57
and 0.75 for "general health perception". Its validity
and reliability have likewise been evaluated scientifi-
cally [35,36]. The short version of the SF-36 that we
use will be recorded by the patient at the beginning
and the end of the inhouse treatment period and again
by telephone by the external evaluation centre at the
end of the ten week follow-up.
V) Rating the indirect flexion and extension ability of the hip or knee 
joint and general patient mobility through the timed "up and go" 
(TUG) test
In its original form, the TUG is an internationally rec-
ognised procedure for rating body balance and the
danger of falling during an everyday task involving
movement. For this reason, it is a standard procedure
in geriatric and general practitioner assessment of
individual patient mobility and risk of falling. The
TUG's validity, inherent consistency, and reliability
are scientifically proved [37]. To carry out the test, the
patient sits on a chair with armrests, which is placed
three metres from a wall. When prompted, the patient
has to stand up, pause in front of the chair, walk the
three metres to the wall, turn around without touching
the wall, walk back to the chair, turn around again and
sit down. The time required, use of aids, and general
feasibility are measured. We use the TUG test, together
with an estimate of general mobility, to rate flexion
and extension of the affected knee or hip joint indi-
rectly, as described previously in the scientific litera-
ture for the indication of osteoarthritis [38]. The TUG
test will be administered by the investigator at the
Schedule of data acquisition Figure 3
Schedule of data acquisition. [pq = physicians questionnaire]. EQ-5D = EuroQol questionnaire; AIMS2-SF = Arthritis 
Impact Measurement Scale.
Admission
2 weeks
after admission
(discharge)
10 weeks
after admission
(telephone interview)
Assessment of joint/ physical
functionality (secondary 
outcome)
Range of motion of the affected joint (flexion und 
extension, possible average improvement) X (pq) X (pq)
Lequesne knee questionnaire xx x
Timed up& go test X (pq) X (pq)
Health-related quality of life
(secondary outcome)
SF-36 (rough evaluation: physical summation 
scale, psychological summation scale) xx x
AIMS2-SF x xx
Assessment of pain
(primary outcome) Visual analog scale X (pq) X (pq)
Measurement of daily pain intensity
by patient diary
(period from admission to discharge)
 
Health assessment
(secondary outcome)
EQ-5D xx x
Measurement of daily state of health by patient 
diary
(period from admission to discharge) x xx
Measurement of daily blood pressure 
by patient diary
(period from admission to discharge)  BMC Musculoskeletal Disorders 2009, 10:104 http://www.biomedcentral.com/1471-2474/10/104
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beginning of the study and again at the end of the
inpatient treatment phase
VI) Standardised survey of state of health based on the EQ-5D test
The EQ-5D test is a standardised international proce-
dure for self-rating of the patient's health status. It is
divided into a general descriptive part and a pain-
related part. The five dimensions rated in the descrip-
tive part are mobility, self-sufficiency, daily activities,
pain or discomfort, and anxiety or depression; the
pain section of the EQ-5D test consists of the visual
analogue scale in the self-rating procedure. In contrast
to the SF 36 and the AIMS2, a more exact rating of eve-
ryday activities and their disease-related restriction is
possible. The inherent consistency and validity of the
EQ-5D test have been well evaluated scientifically
[39].
In the EQ-5D self-rating procedure, results will be
recorded by the patients at the beginning of the study
and at the end of the treatment phase; the external
study evaluation centre will also collect data by tele-
phone ten weeks later.
VII) Blood pressure profile during the inpatient treatment phase
To demonstrate possible concomitant effects of the
inpatient therapy on blood pressure – especially in the
hydrotherapy group and the group combining hydro-
therapy with physiotherapy – nursing staff will record
the patient's blood pressure each day in the patient's
diary.
VIII) Body weight changes during the inpatient phase, based on the 
BMI
The investigator will record the patient's BMI at the
beginning of the study and at the end of the inpatient
treatment phase.
Statistical analysis
The data will be analysed using SPSS 15.0 (SPSS inc.,
2006) software according to the intention-to-treat princi-
ple. Accordingly, all patients with valid values will be
included in such a way that they remain in the groups in
which they were originally randomised, irrespective of the
treatment they actually received.
To check the homogeneity of the groups, a cross-sectional
comparison of the baseline characteristics will be carried
out. Various statistical procedures will be applied,
depending on the scale level in each case. A factorial anal-
ysis of variance (one way ANOVA), if necessary with
appropriate post hoc tests, will be carried out for the met-
ric variables, body mass index (BMI), age and blood pres-
sure, the scale values in SF-36, AIMS 2-F, visual analogue
scale (VAS), and Lequesne index, the time required in the
timed "up and go" test, and flexion and extension in the
neutral-zero testing,. The nominal variables sex, affected
joint (left, right, both sides) and the items of the EQ-5D
will be analysed with chi-square tests. An analysis of vari-
ance with measured value repetition (ANOVA, repeated
measures) will be performed for the longitudinal analysis
of the primary outcome measure (VAS), and for the sec-
ondary outcome criteria (current mental health state, SF-
36 sum scales, AIMS 2-SF scales, Lequesne index, time
required in the timed "up and go" test, flexion and exten-
sion in the neutral-zero testing, and blood pressure)
which are also metric variables. Should, contrary to expec-
tations, there be any inhomogeneity between the groups
with respect to important variables (baseline characteris-
tics), adjustments will be made as far as possible in the
scope of the longitudinal analysis. The secondary out-
come measures on the nominal data level (EQ-5D) will be
analysed with chi-square tests.
Feasibility of the study design
A pilot study was carried out between June 2008 and Jan-
uary 2009 to check the practicability, the treatment proto-
cols, and the randomisation procedure. Patients were
recruited at a specialist clinic in Germany. A total of 30
patients with symptomatic osteoarthritis of the hip or
knee joint were randomised into intervention group A
(hydrotherapy), intervention group B (physiotherapy) or
the control group C (physiotherapy and hydrotherapy).
The results of this pilot study showed that all study proce-
dures, therapeutic interventions, and randomisation pro-
cedures were practicable and feasible; there was no
disqualification on account of unwanted adverse reac-
tions or side effects. All physicians and therapists reported
problem-free implementation of the study protocol and
efficient study coordination.
Discussion
The increasing age of the population, particularly in the
western world, means that the prevalence of osteoarthritis
of the hip and knee is also increasing, with corresponding
socioeconomic consequences [40,1]. In the reasons for all
visits to a general practitioner in Germany, osteoarthritis
of the hip and knee come in places 14 and 34, respec-
tively; they come in the third and ninth places for ortho-
paedic consultations [41].
Although there is currently no curative intervention, in
accordance with US and European guidelines, pharmaco-
therapeutic and non-pharmacological approaches aim at
pain control and the reduction of functional restriction.
The development of more efficient, cost-effective, sustain-
able therapeutic strategies with fewer side effects is thus
gaining in significance.BMC Musculoskeletal Disorders 2009, 10:104 http://www.biomedcentral.com/1471-2474/10/104
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It has been established that hydrotherapy for osteoarthri-
tis of the hip or knee joint using serial cold and warm
water stimulation not only improves the range of move-
ment in the affected joint but also provides significant
pain relief and increases quality of life over a period of up
to three months [11,25]. Even so, there is only scattered
evidence from RCTs or meta-analyses which investigate
the use of hydrotherapy for osteoarthritis with respect to
its long-term and sustained effects [18].
For this reason, we designed this study to evaluate the effi-
ciency of hydrotherapy of the affected joint, in the form of
alternate cold and warm Kneipp affusions, in patients
with symptomatic osteoarthritis of the hip or knee, in
comparison with conventional physiotherapy.
The statistical analysis of the study result will follow the
intention-to-treat principle.
The study has limitations, however: hydrotherapy in
patients with symptomatic osteoarthritis will be studied
in comparison with conventional physiotherapy in the
context of a two-week inpatient stay in a well-known Ger-
man specialist clinic for integrative medicine and centre
for hydrotherapy, with ten weeks' subsequent observa-
tion. Possible secondary intervention parameters, such as
simultaneous sports activity, movement therapy, nutri-
tional therapy or dietary measures for weight reduction of
obese patients with osteoarthritis during their inpatient
stay were not included in the pilot study, nor will they be
in the main study. For one thing, the hydrotherapy will
not be continued during the ten week observation phase
and, for another, the intake of phytotherapeutics and
nutritional supplements will not be studied. These will be
the subjects of further RCTs.
However, the results of our pilot study have shown that
the study procedures, therapeutic interventions and ran-
domisation procedure are all practicable and feasible. In
addition we observed positive long-term effects of the
hydrotherapy with respect to pain and quality of life.
This study design is based on the CONSORT statement for
randomised, controlled studies [42].
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